Menu

A Reprogramming Histone

The scientist who pioneered cloning has found that a histone may act as a cellular reset button.  

Oct 29, 2012
Beth Marie Mole

Wikimedia, Toni BarrosIn the 1996 experiment that created the famous sheep Dolly, researchers swapped the nucleus of an unfertilized egg with that of a differentiated adult cell, which rebooted the adult nucleus to create the first cloned mammal. Now, John B. Gurdon of the Gurdon Institute in Cambridge and colleagues—who developed the technique and shared the Nobel Prize in Physiology or Medicine this year—have found that a histone variant, H3.3, plays a central role in transitioning an adult cell’s nucleus to a blank-slate capable of developing into any of the body’s cells.

"Manipulating the H3.3 pathway may provide a way to completely wipe a cell's ‘memory’ and produce a truly pluripotent cell,” geneticist Steven Henikoff, from the Fred Hutchinson Cancer Research Center, said in a press release. The results, published today (October 29) in Epigenetics & Chromatin, could have implications for regenerative medicine and other therapies, he added, which are beginning to use reprogrammed cells but still face difficulties, including low efficiency. “[It] suggests that chromatin is a sticking point preventing artificially induced reprogramming [from] being used routinely in the clinic."

For the experiment, Gurdon and colleagues implanted a nucleus from an adult mouse cell into an enucleated frog egg—similar to his first groundbreaking nuclear transfer experiment in 1962—and added fluorescently labeled histones, around which strands of DNA wrap, making certain genes available or unavailable for transcription.

"Using real-time microscopy it became apparent that from 10 hours onwards, H3.3 . . . became incorporated into the transplanted nucleus,” explained Gurdon in the press release. The team noted that H3.3’s placement in the DNA coincided with regions important for the regulation of key pluripotency genes, such as Oct4. The researchers also found that the nucleus wouldn’t reprogram without H3.3 present.

The finding suggests that this histone variant is necessary for global genome changes that control the cell fate, the authors wrote in the study.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!